QuantumScape is about to let investors know if its pilot production "Eagle Line" is delivering battery cells to customers.

Pfizer is facing patent cliffs on multiple drugs in the next few years. The company has been making big acquisitions to ...

Apple's earnings are expected to increase by a healthy 14% in the current fiscal year to $8.51 per share, according to ...

The telecom giant's turnaround is gaining traction, but the market is still pricing the stock for continued challenges.

Lululemon Athletica (LULU +2.65%) has lost close to half of its valuation over the past five years. Investors have been ...

Chinese electric vehicles are quickly becoming a dominant force in the industry, but it hasn’t necessarily translated into ...

In this episode, Fool contributors discuss recent financial results from banking giants Bank of America and Charles Schwab ...

Expense ratios, yield, and sector exposure set these two global ETFs apart. See how their differences could impact your ...

The Iran ceasefire didn't fix the world's helium shortage problem. The Strait of Hormuz being militarily contested is how the ...

Explore how sector focus and portfolio breadth set these two growth ETFs apart for investors weighing diversification against ...

Capitalizing on multiple long-term growth catalysts. Brookfield is in the middle of a transformative growth phase, driven by ...

The agentic AI platform provider made additional acquisitions in 2025 and started the new year strong by acquiring Reward ...